Items where Author is "Mulick Cassidy, A"
Up a level |
Number of items: 12.
2018
Mulick, A;
Walker, J;
Puntis, S;
Burke, K;
Symeonides, S;
Gourley, C;
Wanat, M;
Frost, C;
Sharpe, M;
(2018)
Does depression treatment improve the survival of depressed patients with cancer? A long-term follow-up of participants in the SMaRT Oncology-2 and 3 trials.
The lancet Psychiatry.
ISSN 2215-0366
DOI: https://doi.org/10.1016/S2215-0366(18)30061-0
Mulick, AR;
Allen, V;
Williams, HC;
Grindlay, DJC;
Pearce, N;
Abuabara, K;
Langan, SM;
(2018)
Classifying atopic dermatitis: protocol for a systematic review of subtypes (phenotypes) and associated characteristics.
BMJ open, 8 (9).
e023097.
ISSN 2044-6055
DOI: https://doi.org/10.1136/bmjopen-2018-023097
Walker, J;
Burke, K;
Wanat, M;
Fisher, R;
Fielding, J;
Mulick, A;
Puntis, S;
Sharpe, J;
Esposti, MD;
Harriss, E;
+2 more...
Frost, C;
Sharpe, M;
(2018)
The prevalence of depression in general hospital inpatients: a systematic review and meta-analysis of interview-based studies.
Psychological medicine.
pp. 1-14.
ISSN 0033-2917
DOI: https://doi.org/10.1017/S0033291718000624
2017
Frost, C;
Mulick, A;
Scahill, RI;
Owen, G;
Aylward, E;
Leavitt, BR;
Durr, A;
Roos, RAC;
Borowsky, B;
Stout, JC;
+5 more...
Reilmann, R;
Langbehn, DR;
Tabrizi, SJ;
Sampaio, C;
TRACK-HD Investigators;
(2017)
Design optimization for clinical trials in early-stage manifest Huntington's disease.
Movement disorders.
ISSN 0885-3185
DOI: https://doi.org/10.1002/mds.27122
Wanat, M;
Walker, J;
Burke, K;
Sevdalis, N;
Richardson, A;
Mulick, A;
Frost, C;
Sharpe, M;
(2017)
Linked symptom monitoring and depression treatment programmes for specialist cancer services: protocol for a mixed-methods implementation study.
BMJ open, 7 (6).
e016186.
ISSN 2044-6055
DOI: https://doi.org/10.1136/bmjopen-2017-016186
2016
Charoen, P;
Nitsch, D;
Engmann, J;
Shah, T;
White, J;
Zabaneh, D;
Jefferis, B;
Wannamethee, G;
Whincup, P;
Mulick Cassidy, A;
+31 more...
Gaunt, T;
Day, I;
McLachlan, S;
Price, J;
Kumari, M;
Kivimaki, M;
Brunner, E;
Langenberg, C;
Ben-Shlomo, Y;
Hingorani, A;
Whittaker, J;
Pablo Casas, J;
Dudbridge, F;
UCLEB Consortium;
, COLLABORATORS;
Dale, C;
Finan, C;
Wong, A;
Ong, K;
Drenos, F;
Cooper, J;
Sofat, R;
Schmidt, F;
Lawlor, DA;
Talmud, PJ;
Humphries, SE;
Hardy, R;
Kuh, D;
Wareham, N;
Morris, R;
Plagno, V;
(2016)
Mendelian Randomisation study of the influence of eGFR on coronary heart disease.
Scientific reports, 6.
p. 28514.
ISSN 2045-2322
DOI: https://doi.org/10.1038/srep28514
Labuschagne, I;
Cassidy, AM;
Scahill, RI;
Johnson, EB;
Rees, E;
O'Regan, A;
Queller, S;
Frost, C;
Leavitt, BR;
Dürr, A;
+6 more...
Roos, R;
Owen, G;
Borowsky, B;
Tabrizi, SJ;
Stout, JC;
TRACK-HD Investigators;
(2016)
Visuospatial Processing Deficits Linked to Posterior Brain Regions in Premanifest and Early Stage Huntington's Disease.
Journal of the International Neuropsychological Society.
pp. 1-14.
ISSN 1355-6177
DOI: https://doi.org/10.1017/S1355617716000321
2013
Omlin, A;
Pezaro, C;
Mukherji, D;
Mulick Cassidy, A;
Sandhu, S;
Bianchini, D;
Olmos, D;
Ferraldeschi, R;
Maier, G;
Thompson, E;
+3 more...
Parker, C;
Attard, G;
de Bono, J;
(2013)
Improved survival in a cohort of trial participants with metastatic castration-resistant prostate cancer demonstrates the need for updated prognostic nomograms.
European urology, 64 (2).
pp. 300-6.
ISSN 0302-2838
DOI: https://doi.org/10.1016/j.eururo.2012.12.029
Full text not available from this repository.
Pezaro, C;
Mukherji, D;
Tunariu, N;
Cassidy, AM;
Omlin, A;
Bianchini, D;
Seed, G;
Reid, AH;
Olmos, D;
de Bono, JS;
+1 more...
Attard, G;
(2013)
Sarcopenia and change in body composition following maximal androgen suppression with abiraterone in men with castration-resistant prostate cancer.
British journal of cancer, 109 (2).
pp. 325-31.
ISSN 0007-0920
DOI: https://doi.org/10.1038/bjc.2013.340
2012
Attard, G;
Reid, AH;
Auchus, RJ;
Hughes, BA;
Cassidy, AM;
Thompson, E;
Oommen, NB;
Folkerd, E;
Dowsett, M;
Arlt, W;
+1 more...
de Bono, JS;
(2012)
Clinical and biochemical consequences of CYP17A1 inhibition with abiraterone given with and without exogenous glucocorticoids in castrate men with advanced prostate cancer.
The Journal of clinical endocrinology and metabolism, 97 (2).
pp. 507-16.
ISSN 0021-972X
DOI: https://doi.org/10.1210/jc.2011-2189
Full text not available from this repository.
Perkins, G;
Yap, TA;
Pope, L;
Cassidy, AM;
Dukes, JP;
Riisnaes, R;
Massard, C;
Cassier, PA;
Miranda, S;
Clark, J;
+8 more...
Denholm, KA;
Thway, K;
Gonzalez De Castro, D;
Attard, G;
Molife, LR;
Kaye, SB;
Banerji, U;
de Bono, JS;
(2012)
Multi-purpose utility of circulating plasma DNA testing in patients with advanced cancers.
PloS one, 7 (11).
e47020.
ISSN 1932-6203
DOI: https://doi.org/10.1371/journal.pone.0047020
2011
Ligthart, ST;
Coumans, FA;
Attard, G;
Cassidy, AM;
de Bono, JS;
Terstappen, LW;
(2011)
Unbiased and automated identification of a circulating tumour cell definition that associates with overall survival.
PloS one, 6 (11).
e27419.
ISSN 1932-6203
DOI: https://doi.org/10.1371/journal.pone.0027419